Walleye Capital
MRK icon

Walleye Capital’s Merck MRK Stock Holding History

Walleye Capital’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26M Buy
202,500
+97,800
+93% +$11.4M 0.09% 184
2026
Q1 		$12.6M Sell
104,700
-77,200
-42% -$8.91M 0.05% 322
2025
Q4 		$19.1M Sell
181,900
-88,800
-33% -$8.34M 0.06% 312
2025
Q3 		$22.7M Sell
270,700
-65,100
-19% -$5.36M 0.09% 217
2025
Q2 		$26.6M Buy
335,800
+179,400
+115% +$14.3M 0.1% 152
2025
Q1 		$14M Sell
156,400
-103,500
-40% -$9.66M 0.06% 303
2024
Q4 		$25.9M Sell
259,900
-93,000
-26% -$9.59M 0.06% 248
2024
Q3 		$40.1M Sell
352,900
-75,800
-18% -$9.01M 0.08% 153
2024
Q2 		$53.1M Sell
428,700
-130,100
-23% -$16.8M 0.09% 124
2024
Q1 		$73.7M Buy
558,800
+125,600
+29% +$15.5M 0.13% 86
2023
Q4 		$47.2M Buy
433,200
+284,100
+191% +$29.5M 0.1% 115
2023
Q3 		$15.3M Sell
149,100
-58,600
-28% -$6.32M 0.04% 364
2023
Q2 		$24M Buy
207,700
+65,700
+46% +$7.46M 0.09% 123
2023
Q1 		$15.1M Buy
142,000
+86,100
+154% +$9.3M 0.23% 76
2022
Q4 		$6.2M Sell
55,900
-27,500
-33% -$2.81M 0.11% 222
2022
Q3 		$7.18M Buy
+83,400
New +$7.45M 0.14% 161
2020
Q1 		– Sell
-14,672
Closed -$1.27M – 1397
2019
Q4 		$1.27M Sell
14,672
-117,062
-89% -$9.61M 0.08% 332
2019
Q3 		$10.6M Buy
131,734
+67,701
+106% +$5.43M 0.63% 12
2019
Q2 		$5.12M Buy
64,033
+23,999
+60% +$1.84M 0.56% 9
2019
Q1 		$3.18M Buy
+40,034
New +$2.99M 0.52% 3
2018
Q3 		$482K Buy
+7,126
New +$454K 0.22% 134

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Walleye Capital's MRK Position: Q2 2026 in Review

Walleye Capital reduced its Merck (MRK) stake by 99% in Q2 2026, selling an estimated $20.2M and leaving 2,129 shares worth $274K. The position accounts for ﹤0.01% of the portfolio, ranked #3244.

Walleye Capital first reported a position in MRK in Q2 2020 and has held it in 17 quarters since. The position peaked at $41.2M in Q3 2024. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Walleye Capital held 2,129 shares of Merck worth $274K as of Q2 2026.
  • Walleye Capital sold 172,543 Merck shares in Q2 2026, an estimated $20.2M.
  • Merck made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #3244 holding.
  • Walleye Capital first reported a position in Merck in Q2 2020 and has held it in 17 quarters since.
  • Walleye Capital's Merck position peaked at $41.2M in Q3 2024.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.